世界の女性健康管理市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Women Health Care Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z6078 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、女性健康管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（デノスマブ、ラロキシフェン、レボノルゲストレル、ゾレドロン酸、リセドロン酸、その他）、用途別市場規模（女性不妊症、閉経後骨粗鬆症、子宮内膜症、避妊、多嚢胞性卵巣症候群（PCOS）、閉経、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・女性健康管理の市場動向 ・企業の競争状況、市場シェア ・女性健康管理の種類別市場規模（デノスマブ、ラロキシフェン、レボノルゲストレル、ゾレドロン酸、リセドロン酸、その他） ・女性健康管理の用途別市場規模（女性不妊症、閉経後骨粗鬆症、子宮内膜症、避妊、多嚢胞性卵巣症候群（PCOS）、閉経、その他） ・女性健康管理の北米市場規模2016-2027（アメリカ、カナダ） ・女性健康管理のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性健康管理のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性健康管理の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性健康管理の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer AG、Allergan、Merck、Pfizer、Amgen、Agile Therapeutics、Ferring Pharmaceuticals、Mylan、Eli Lilly、Novartis、Johnson & Johnson、Lupin Limited） ・結論

Market Analysis and Insights: Global Women Health Care Market
The global Women Health Care market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Women Health Care market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Women Health Care market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Women Health Care market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Women Health Care market.

Global Women Health Care Scope and Market Size
Women Health Care market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Women Health Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Denosumab
Raloxifene
Levonorgestrel
Zoledronic Acid
Risedronic Acid
Other

Segment by Application
Female Infertility
Postmenopausal Osteoporosis
Endometriosis
Contraception
Polycystic Ovary Syndrome (PCOS)
Menopause
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer AG
Allergan
Merck
Pfizer
Amgen
Agile Therapeutics
Ferring Pharmaceuticals
Mylan
Eli Lilly
Novartis

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women Health Care Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Denosumab
1.2.3 Raloxifene
1.2.4 Levonorgestrel
1.2.5 Zoledronic Acid
1.2.6 Risedronic Acid
1.2.7 Other
1.3 Market by Application
1.3.1 Global Women Health Care Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Female Infertility
1.3.3 Postmenopausal Osteoporosis
1.3.4 Endometriosis
1.3.5 Contraception
1.3.6 Polycystic Ovary Syndrome (PCOS)
1.3.7 Menopause
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Women Health Care Market Perspective (2016-2027)
2.2 Women Health Care Growth Trends by Regions
2.2.1 Women Health Care Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Women Health Care Historic Market Share by Regions (2016-2021)
2.2.3 Women Health Care Forecasted Market Size by Regions (2022-2027)
2.3 Women Health Care Industry Dynamic
2.3.1 Women Health Care Market Trends
2.3.2 Women Health Care Market Drivers
2.3.3 Women Health Care Market Challenges
2.3.4 Women Health Care Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Women Health Care Players by Revenue
3.1.1 Global Top Women Health Care Players by Revenue (2016-2021)
3.1.2 Global Women Health Care Revenue Market Share by Players (2016-2021)
3.2 Global Women Health Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Women Health Care Revenue
3.4 Global Women Health Care Market Concentration Ratio
3.4.1 Global Women Health Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women Health Care Revenue in 2020
3.5 Women Health Care Key Players Head office and Area Served
3.6 Key Players Women Health Care Product Solution and Service
3.7 Date of Enter into Women Health Care Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Women Health Care Breakdown Data by Type
4.1 Global Women Health Care Historic Market Size by Type (2016-2021)
4.2 Global Women Health Care Forecasted Market Size by Type (2022-2027)

5 Women Health Care Breakdown Data by Application
5.1 Global Women Health Care Historic Market Size by Application (2016-2021)
5.2 Global Women Health Care Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Women Health Care Market Size (2016-2027)
6.2 North America Women Health Care Market Size by Type
6.2.1 North America Women Health Care Market Size by Type (2016-2021)
6.2.2 North America Women Health Care Market Size by Type (2022-2027)
6.2.3 North America Women Health Care Market Size by Type (2016-2027)
6.3 North America Women Health Care Market Size by Application
6.3.1 North America Women Health Care Market Size by Application (2016-2021)
6.3.2 North America Women Health Care Market Size by Application (2022-2027)
6.3.3 North America Women Health Care Market Size by Application (2016-2027)
6.4 North America Women Health Care Market Size by Country
6.4.1 North America Women Health Care Market Size by Country (2016-2021)
6.4.2 North America Women Health Care Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Women Health Care Market Size (2016-2027)
7.2 Europe Women Health Care Market Size by Type
7.2.1 Europe Women Health Care Market Size by Type (2016-2021)
7.2.2 Europe Women Health Care Market Size by Type (2022-2027)
7.2.3 Europe Women Health Care Market Size by Type (2016-2027)
7.3 Europe Women Health Care Market Size by Application
7.3.1 Europe Women Health Care Market Size by Application (2016-2021)
7.3.2 Europe Women Health Care Market Size by Application (2022-2027)
7.3.3 Europe Women Health Care Market Size by Application (2016-2027)
7.4 Europe Women Health Care Market Size by Country
7.4.1 Europe Women Health Care Market Size by Country (2016-2021)
7.4.2 Europe Women Health Care Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Women Health Care Market Size (2016-2027)
8.2 Asia-Pacific Women Health Care Market Size by Type
8.2.1 Asia-Pacific Women Health Care Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Women Health Care Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Women Health Care Market Size by Type (2016-2027)
8.3 Asia-Pacific Women Health Care Market Size by Application
8.3.1 Asia-Pacific Women Health Care Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Women Health Care Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Women Health Care Market Size by Application (2016-2027)
8.4 Asia-Pacific Women Health Care Market Size by Region
8.4.1 Asia-Pacific Women Health Care Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Women Health Care Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Women Health Care Market Size (2016-2027)
9.2 Latin America Women Health Care Market Size by Type
9.2.1 Latin America Women Health Care Market Size by Type (2016-2021)
9.2.2 Latin America Women Health Care Market Size by Type (2022-2027)
9.2.3 Latin America Women Health Care Market Size by Type (2016-2027)
9.3 Latin America Women Health Care Market Size by Application
9.3.1 Latin America Women Health Care Market Size by Application (2016-2021)
9.3.2 Latin America Women Health Care Market Size by Application (2022-2027)
9.3.3 Latin America Women Health Care Market Size by Application (2016-2027)
9.4 Latin America Women Health Care Market Size by Country
9.4.1 Latin America Women Health Care Market Size by Country (2016-2021)
9.4.2 Latin America Women Health Care Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Women Health Care Market Size (2016-2027)
10.2 Middle East & Africa Women Health Care Market Size by Type
10.2.1 Middle East & Africa Women Health Care Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Women Health Care Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Women Health Care Market Size by Type (2016-2027)
10.3 Middle East & Africa Women Health Care Market Size by Application
10.3.1 Middle East & Africa Women Health Care Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Women Health Care Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Women Health Care Market Size by Application (2016-2027)
10.4 Middle East & Africa Women Health Care Market Size by Country
10.4.1 Middle East & Africa Women Health Care Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Women Health Care Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Women Health Care Introduction
11.1.4 Bayer AG Revenue in Women Health Care Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Women Health Care Introduction
11.2.4 Allergan Revenue in Women Health Care Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Women Health Care Introduction
11.3.4 Merck Revenue in Women Health Care Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Women Health Care Introduction
11.4.4 Pfizer Revenue in Women Health Care Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Women Health Care Introduction
11.5.4 Amgen Revenue in Women Health Care Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Agile Therapeutics
11.6.1 Agile Therapeutics Company Details
11.6.2 Agile Therapeutics Business Overview
11.6.3 Agile Therapeutics Women Health Care Introduction
11.6.4 Agile Therapeutics Revenue in Women Health Care Business (2016-2021)
11.6.5 Agile Therapeutics Recent Development
11.7 Ferring Pharmaceuticals
11.7.1 Ferring Pharmaceuticals Company Details
11.7.2 Ferring Pharmaceuticals Business Overview
11.7.3 Ferring Pharmaceuticals Women Health Care Introduction
11.7.4 Ferring Pharmaceuticals Revenue in Women Health Care Business (2016-2021)
11.7.5 Ferring Pharmaceuticals Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Women Health Care Introduction
11.8.4 Mylan Revenue in Women Health Care Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Women Health Care Introduction
11.9.4 Eli Lilly Revenue in Women Health Care Business (2016-2021)
11.9.5 Eli Lilly Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Women Health Care Introduction
11.10.4 Novartis Revenue in Women Health Care Business (2016-2021)
11.10.5 Novartis Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Details
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Women Health Care Introduction
11.11.4 Johnson & Johnson Revenue in Women Health Care Business (2016-2021)
11.11.5 Johnson & Johnson Recent Development
11.12 Lupin Limited
11.12.1 Lupin Limited Company Details
11.12.2 Lupin Limited Business Overview
11.12.3 Lupin Limited Women Health Care Introduction
11.12.4 Lupin Limited Revenue in Women Health Care Business (2016-2021)
11.12.5 Lupin Limited Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Women Health Care Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Denosumab
Table 3. Key Players of Raloxifene
Table 4. Key Players of Levonorgestrel
Table 5. Key Players of Zoledronic Acid
Table 6. Key Players of Risedronic Acid
Table 7. Key Players of Other
Table 8. Global Women Health Care Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Women Health Care Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Women Health Care Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Women Health Care Market Share by Regions (2016-2021)
Table 12. Global Women Health Care Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Women Health Care Market Share by Regions (2022-2027)
Table 14. Women Health Care Market Trends
Table 15. Women Health Care Market Drivers
Table 16. Women Health Care Market Challenges
Table 17. Women Health Care Market Restraints
Table 18. Global Women Health Care Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Women Health Care Market Share by Players (2016-2021)
Table 20. Global Top Women Health Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women Health Care as of 2020)
Table 21. Ranking of Global Top Women Health Care Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Women Health Care Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Women Health Care Product Solution and Service
Table 25. Date of Enter into Women Health Care Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Women Health Care Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Women Health Care Revenue Market Share by Type (2016-2021)
Table 29. Global Women Health Care Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Women Health Care Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Women Health Care Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Women Health Care Revenue Market Share by Application (2016-2021)
Table 33. Global Women Health Care Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Women Health Care Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Women Health Care Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Women Health Care Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Women Health Care Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Women Health Care Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Women Health Care Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Women Health Care Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Women Health Care Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Women Health Care Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Women Health Care Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Women Health Care Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Women Health Care Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Women Health Care Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Women Health Care Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Women Health Care Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Women Health Care Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Women Health Care Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Women Health Care Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Women Health Care Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Women Health Care Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Women Health Care Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Women Health Care Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Women Health Care Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Women Health Care Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Women Health Care Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Women Health Care Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Women Health Care Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Women Health Care Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Women Health Care Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Women Health Care Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Women Health Care Market Size by Country (2022-2027) & (US$ Million)
Table 65. Bayer AG Company Details
Table 66. Bayer AG Business Overview
Table 67. Bayer AG Women Health Care Product
Table 68. Bayer AG Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 69. Bayer AG Recent Development
Table 70. Allergan Company Details
Table 71. Allergan Business Overview
Table 72. Allergan Women Health Care Product
Table 73. Allergan Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 74. Allergan Recent Development
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Women Health Care Product
Table 78. Merck Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 79. Merck Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Women Health Care Product
Table 83. Pfizer Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Amgen Company Details
Table 86. Amgen Business Overview
Table 87. Amgen Women Health Care Product
Table 88. Amgen Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 89. Amgen Recent Development
Table 90. Agile Therapeutics Company Details
Table 91. Agile Therapeutics Business Overview
Table 92. Agile Therapeutics Women Health Care Product
Table 93. Agile Therapeutics Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 94. Agile Therapeutics Recent Development
Table 95. Ferring Pharmaceuticals Company Details
Table 96. Ferring Pharmaceuticals Business Overview
Table 97. Ferring Pharmaceuticals Women Health Care Product
Table 98. Ferring Pharmaceuticals Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 99. Ferring Pharmaceuticals Recent Development
Table 100. Mylan Company Details
Table 101. Mylan Business Overview
Table 102. Mylan Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 103. Mylan Recent Development
Table 104. Eli Lilly Company Details
Table 105. Eli Lilly Business Overview
Table 106. Eli Lilly Women Health Care Product
Table 107. Eli Lilly Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 108. Eli Lilly Recent Development
Table 109. Novartis Company Details
Table 110. Novartis Business Overview
Table 111. Novartis Women Health Care Product
Table 112. Novartis Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 113. Novartis Recent Development
Table 114. Johnson & Johnson Company Details
Table 115. Johnson & Johnson Business Overview
Table 116. Johnson & Johnson Women Health Care Product
Table 117. Johnson & Johnson Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 118. Johnson & Johnson Recent Development
Table 119. Lupin Limited Company Details
Table 120. Lupin Limited Business Overview
Table 121. Lupin Limited Women Health Care Product
Table 122. Lupin Limited Revenue in Women Health Care Business (2016-2021) & (US$ Million)
Table 123. Lupin Limited Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Women Health Care Market Share by Type: 2020 VS 2027
Figure 2. Denosumab Features
Figure 3. Raloxifene Features
Figure 4. Levonorgestrel Features
Figure 5. Zoledronic Acid Features
Figure 6. Risedronic Acid Features
Figure 7. Other Features
Figure 8. Global Women Health Care Market Share by Application: 2020 VS 2027
Figure 9. Female Infertility Case Studies
Figure 10. Postmenopausal Osteoporosis Case Studies
Figure 11. Endometriosis Case Studies
Figure 12. Contraception Case Studies
Figure 13. Polycystic Ovary Syndrome (PCOS) Case Studies
Figure 14. Menopause Case Studies
Figure 15. Others Case Studies
Figure 16. Women Health Care Report Years Considered
Figure 17. Global Women Health Care Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Women Health Care Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Women Health Care Market Share by Regions: 2020 VS 2027
Figure 20. Global Women Health Care Market Share by Regions (2022-2027)
Figure 21. Global Women Health Care Market Share by Players in 2020
Figure 22. Global Top Women Health Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women Health Care as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Women Health Care Revenue in 2020
Figure 24. Global Women Health Care Revenue Market Share by Type (2016-2021)
Figure 25. Global Women Health Care Revenue Market Share by Type (2022-2027)
Figure 26. North America Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Women Health Care Market Share by Type (2016-2027)
Figure 28. North America Women Health Care Market Share by Application (2016-2027)
Figure 29. North America Women Health Care Market Share by Country (2016-2027)
Figure 30. United States Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Women Health Care Market Share by Type (2016-2027)
Figure 34. Europe Women Health Care Market Share by Application (2016-2027)
Figure 35. Europe Women Health Care Market Share by Country (2016-2027)
Figure 36. Germany Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Women Health Care Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Women Health Care Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Women Health Care Market Share by Region (2016-2027)
Figure 46. China Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Women Health Care Market Share by Type (2016-2027)
Figure 54. Latin America Women Health Care Market Share by Application (2016-2027)
Figure 55. Latin America Women Health Care Market Share by Country (2016-2027)
Figure 56. Mexico Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Women Health Care Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Women Health Care Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Women Health Care Market Share by Country (2016-2027)
Figure 62. Turkey Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Women Health Care Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Bayer AG Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 66. Allergan Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 69. Amgen Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 70. Agile Therapeutics Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 71. Ferring Pharmaceuticals Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 72. Mylan Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 73. Eli Lilly Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 74. Novartis Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 75. Johnson & Johnson Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 76. Lupin Limited Revenue Growth Rate in Women Health Care Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---